Question Is an artificial intelligence (AI)–driven TPNS device superior to a sham device in reducing essential tremor? Findings In this randomized clinical trial that included 125 adults with essential tremor, use of the TPNS device reduced the modified Activities of Daily Living score of the Essential Tremor Rating Assessment Scale by a clinically meaningful 6.9 points at […]
Researchers have identified a neurochemical signature that sets Parkinson’s disease apart from essential tremor — two of the most common movement disorders, but each linked to distinct changes in the brain. In a new study published September 2, 2025 in Nature Communications, scientists from Virginia Tech’s Fralin Biomedical Research Institute at VTC and the College of Science identified unique chemical […]
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today provided an update on the interim analysis for Study 1 of the Essential3 program of ulixacaltamide in essential […]
DALLAS – June 18, 2024 – A statistical tool designed to analyze 11 characteristics of postmortem brains reliably diagnosed a common neurodegenerative disease known as essential tremor (ET), a study led by researchers at UT Southwestern Medical Center and Columbia University shows. Their findings, 20 years in the making and published in the Annals of Clinical and Translational Neurology, […]
Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
(MINNEAPOLIS, Minn.) January 29, 2024 – Fasikl, a Minnesota-based neuro-AI company, announces the completion of two prospective studies for their Felix™ NeuroAI™ Wristband, a wearable technology specifically engineered to offer all-day relief from tremors for adults suffering from a condition known as essential tremor. Results from the studies simultaneously conducted in the United States (US) and […]
BOSTON and SHANGHAI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced an exclusive collaboration and license agreement with Tenacia Biotechnology (Shanghai) Company, Ltd., a China-based clinical-stage biopharmaceutical […]
Source: The Mayo Clinic A clinical trial is a research process to find new and better ways to understand, detect, control and treat health conditions. The scientific method is used to find answers to difficult health-related questions. Volunteers are an integral part of the research process. People with a particular disease as well as healthy […]
BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today provided an update on its clinical portfolio at the company’s R&D Day. Praxis’ leaders were joined by two esteemed […]
June 15, 2023 – By Gina Shaw, Neurology Today The incidence of Parkinson’s disease (PD) in patients with essential tremor (ET) is significantly higher than that reported in historical population-based control groups across numerous countries, according to a prospective longitudinal study published online May 10 in Neurology: Clinical Practice. The findings are consistent with those of […]